Low HPV vaccination rates missed opportunity to prevent cancers

Website intended for a NZ health professional readership

+Practice

In print

HPV vaccination

Low HPV vaccination rates missed opportunity to prevent cancers

6 November 2024

By Amelia Jenkinson, Cathy Stephenson and Swee Tan

Wednesday 6 November 2024, 12:20 AM

HPV_Cervical Cancer_CR_scientificanimations

HPV vaccination rates are below target, making the push to close gaps and reduce cancer rates critical [scientificanimations.com, CC BY-SA 4.0, via Wikimedia Commons]

With over $150 million spent on human papillomavirus-related cancers in three years, improving HPV vaccination rates would cut costs and save lives, write Amelia Jenkinson, Cathy Stephenson and Swee Tan

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.5 credits for continuing professional development purposes (2 , Educate small, BACK panel - grey

Oncology

Vaccines

Women's Health

References

1. Sapere. Economic Burden of HPV-related Cancers. July 2024.

2. Win Myint TT, McIvor N, Douglas R, et al. Incidence, trends and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006–2020. Cancer Epidemiol 2023;85:102393.

How to Treat

+How to treat

Heart failure

Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality

Wednesday 29 January 2025, 12:45 AM